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ABSTRACT 
In  human  peripheral  blood  polymorphonuclear  leukocytes  and  lymphocytes, 
GSH-oxidizing agents promote the  movement of surface-bound concanavalin A 
(Con A) into caps and inhibit the assembly of microtubules (MT) that is normally 
induced by Con A  binding. Con A  capping and inhibition of MT assembly occur 
when GSH levels in cell suspensions are decreased by 30-70%, and return of GSH 
to  control levels  is  accompanied by the  appearance  of cytoplasmic MT and by 
inhibition  of the  capping  response  with  Con  A.  Oxidation  of GSH  markedly 
stimulates  the  hexose  monophosphate  shunt,  and  regeneration  of GSH occurs 
rapidly. 
The data indicate that MT cannot be  assembled or maintained in the face of 
decreased GSH levels. Thus, GSH homeostasis becomes critical during physiolog- 
ical events such as phagocytosis which simultaneously induce the assembly of MT 
and the production of agents like H202 that can oxidize GSH. 
Although a great deal of information  is presently 
available about the conditions required  for micro- 
tubule  (MT)  assembly  in  vitro,  there  is  still no 
clear understanding  of how assembly is regulated 
in  vivo.  Nath  and  Rebhun  (21)  have  recently 
shown  that  oxidation  of  GSH  in  fertilized  sea 
urchin eggs inhibits mitotic spindle formation and 
causes dissolution of preformed spindles. We pro- 
posed  that intracellular  GSH may also influence 
the organization  and function of cytoplasmic MT. 
To test this hypothesis,  we examined the effects of 
GSH oxidation  on the  assembly of MT in human 
peripheral  blood  polymorphonuclear leukocytes 
(PMN).  Two  relatively  specific oxidizing  agents 
were  employed:  diamide  (diazene  dicarboxylic 
and  bis-N,N-dimethylamide)  (15,  16)  and  BHP 
(tertiary  butylhydroperoxide)  (30). 
PMN  were  chosen for study  first because  MT 
assembly  can  be  reproducibly  induced  by brief 
exposure of a variety of ligands including the plant 
lectin concanavalin  A  (Con A) (8,  10,  25),  and 
second because the presence  or absence of MT in 
Con  A-treated  PMN  can  be  inferred  from  the 
distribution of surface-bound  lectin. Thus, Con A 
shows a homogeneous surface distribution  on cells 
that  are  competent to  assemble  MT but  moves 
into a single aggregate-a cap- on the surface of 
cells  treated  with  agents  that  bind  with  tubulin 
subunits  and inhibit their polymerization  (colchi- 
cine  and  the  new  carbamate  anti-MT  agent, 
R17934) (22-27). 
MATERIALS AND  METHODS 
Materials 
Diamide was obtained from the Sigma Chemical Co., 
St.  Louis, Mo.  and  BHP from ICN Pharmaceuticals, 
Inc., Cleveland, Ohio. Con A  (3  x  crystalline) was 
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the most selective  of a  group of GSH-oxidizing agents 
developed by Kosower and co-workers (15,  16),  1 mol 
of this compound oxidizes 2 tool of GSH in a two-step 
chemical  reaction which  produces GSSG plus  inert re- 
duced diamide. In erythrocytes, Kosower et al. showed 
that GSH can be regenerated at 370C after exhaustion or 
removal of diamide in the presence of glucose  and an 
intact hexose monophosphate shunt (HMS). BHP is an 
organic hydroperoxide that serves as a substrate for GSH 
peroxidase and is not decomposed by catalase. Srivistava 
and co-workers (30) have shown that BHP is as effective 
as diamide in oxidizing erythrocyte GSH. As for diam- 
ide, the reaction with GSH is stoichiometric, and sponta- 
neous regeneration of GSH  follows  exhaustion of the 
BHP. Srivistava et al. (30) reported that diamide leads to 
the formation of a small proportion of mixed disulfides of 
GSH with protein sulfhydryls,  whereas BHP and other 
organic  hydroperoxides appear  to  specifically  convert 
GSH to GSSG. 
Cells 
Leukocytes from peripheral blood of normal human 
donors were isolated from buffy coat as previously  de- 
scribed (24,  26).  Cell  suspensions contained approxi- 
mately 80% PMN and 20% mononuclear cells. 
Fluorescence Labeling of Cells 
Cells (106 leukocytes in 0.5 ml of phosphate-buffered 
saline  [PBS]) were labeled at 37~  for 5 min with fluo- 
rescein isothiocyanate-conjugated  con A (FITC-Con A), 
10 p.g/ml, then fixed, washed, and examined as before 
(24, 26). PMN were identified by phase-contrast micros- 
copy before scoring the surface distribution of FITC-Con 
A. The distribution of fluorescence was observed on at 
least  100  cells  in  any  experimental group.  Data  are 
expressed as  percent of random,  capped,  or  patched 
cells.  As described previously, randomly labeled cells 
show a uniform distribution of FITC-Con A, and capped 
cells show FITC-Con A  concentrated in a single  polar 
aggregate  on the membrane. Patched cells show small 
fluorescent aggregates that are intracellular  and cannot 
be removed with the competing sugar a-methyl-D-man- 
nose presumably due to pinocytic internalization of lectin 
during the labeling period. 
Electron Microscopy 
In all experiments, leukocytes (4 x  10  ~ cells in 0.5 ml 
PBS) were incubated at 37~  for 5 min with (in the case 
of treated cells) or without (in the case of untreated cells) 
100  p.g/ml Con A. Diamide and BHP were given at a 
concentration of 50 nmol/10  e cells either during a prein- 
cubation period (5 min at 37~  for diamide, 10 min at 
37~  for  BHP)  or  after  Con  A  treatment.  For  cell 
suspensions pretreated with  drugs, Con  A  was  added 
without immediate washing of the cells. For cell suspen- 
sions post-treated with drugs, Con A  was removed by 
centrifugation before addition of fresh medium contain- 
ing BHP and diamide. After exposure to Con  A  and 
drugs, the cells were pelleted and resuspended for 30 
min at 37~  in fixative consisting of 1% glutaraldehyde 
in 0.1 M sodium cacodylate buffer, pH 7.4. The samples 
were  washed  twice  in  buffer  alone,  postfixed in  2% 
aqueous OsO4 for 30 min, washed in distilled water, and 
stained en bloc for 30 min at 60~  in 2% uranyl acetate 
(aqueous).  Cell  pellets  were  dehydrated  through  a 
graded series of cold ethanols and embedded in an Epon- 
Araldite mixture. Thin sections (silver) cut on a diamond 
knife were picked up on 300-mesh copper grids, stained 
with uranyl acetate and lead, and examined in a Philips 
300 electron microscope. 
Morphometric determinations of centriole-associated 
MT were performed in two ways. The method of Hoff- 
stein et al. (10) was adapted as follows: sections of PMN 
containing a  centriole  were  photographed at  a  stage 
magnification  of x  14,200.  MT were not visible at this 
magnification,  thus precluding sample bias.  They were 
made visible  by printing at a  final  magnification  of x 
53,000.  MT,  recognized by  their straight walls  sepa- 
rated by 24-27 nm and coursing for at least 40 nm, were 
counted within 4  /~m  ~ containing a  centrally  disposed 
centriole. In addition, direct MT counts were made on 
sections viewed in  the electron microscope at  a  stage 
magnification  of x  57,000. An area of approximately 4 
v.m  2  surrounding the centriole was again analyzed for the 
presence of MTs.  This  method of analysis  permitted 
examination of a large number of cells within each exper- 
imental group. However, only long (>80 nm) MT pro- 
files  were  readily  identified, and  the  numerous short 
profiles emanating from the centriolar area and associ- 
ated satellite  structures were not easily  discernible un- 
der these conditions. For each experimental treatment, 
silver sections from three separate pellets were examined 
and analyzed by both direct counting and counting on 
micrographs. 
MT Assembly In Vitro 
Tubulin  was isolated from fresh bovine brain by the 
following modification of the method of Weingarten et 
al. (32). After a cold (4~  high-speed  centrifugation (at 
90,000 g  for 30  min),  initial  MT  polymerization was 
performed by warming the supernate to 37~  for 30 rain 
in 0.1  M  2[N-morpholino]ethane sulfonic  acid  (MES) 
buffer, pH 6.8, containing 1 mM GTP, 1 mM GSH, 0.5 
mM MgCI~, 1.0 mM EGTA, 0.1  mM EDTA, and 2 M 
glycerol. MT were pelleted by high-speed centrifugation 
(90,000 g, 30  min, 250C),  resuspended in cold buffer 
containing 1.0 mM GTP and GSH, and briefly homoge- 
nized in  a  loose-fitting  Dounce  homogenizer (Kontes 
Co., Vineland, N.J.). 
The  rate  and  extent  of  MT  polymerization under 
various experimental conditions were evaluated by meas- 
uring  fluorescence resonance energy transfer between 
mixtures of tubulin  labeled separately with donor and 
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populations  of  tubulin  were  labeled  separately  with 
either FITC or rhodamine  isothiocyanate  (RITC) and 
chromatographed over Sephadex G-25 equilibrated with 
MES buffer to remove uneonjugated dye. Dye to protein 
molar ratios for the protein conjugates used here were 
0.11 for RITC-tubulin and 0.013 for F1TC-tubulin. The 
labeled tubulin was carded through a second depolymer- 
ization-polymerization  cycle  under  the  conditions  de- 
scribed above and used immediately for energy transfer 
experiments in a Perkin-Elmer MPF-4 spectrofluorime- 
ter (Perkin-Elmer Ultek Inc., Palo Alto, Calif.). Assem- 
bly was followed by the increase in the emission peak for 
rhodamine after exciting the sample near the absorption 
maximum for the donor, fluorescein (480 nm). Samples 
from energy transfer experiments were routinely exam- 
ined  by  negative  staining  with  uranyl  acetate  in  the 
electron microscope. 
GSH Measurement 
The levels of GSH in leukocytes were determined by a 
modification of the method of Beutler et al. (2).  Cells 
(12-15  x  10  ~ in 1 ml PBS) were collected by 3-s centrifu- 
gation in an Eppendoff microcentrifuge. Medium was 
removed and immediately replaced by 0.3 ml of precipi- 
tating  solution  (1.67%  [wt/vol]  metaphosphoric  acid, 
30%  [wt/vol] NaCI, 0.2%  [wt/vol] EDTA) plus 0.2 ml 
of  10  mg/ml bovine serum  albumin  (BSA) in  0.25% 
Triton X-100. The tubes were vortexed for 20 s and held 
at room temperature  for at least  10  rain.  Protein was 
pelleted by 2-min centrifugation in the Eppendorf micro- 
centrifuge. GSH assay  mixtures contained protein-free 
supernate  (0.2  ml),  0.3  M  Na2HPO4  (0.7  ml),  and 
0.04%  5,5'-dithiobis(2-nitrobenzoic  acid)  (DTNB)  in 
1% sodium citrate (0.1  ml). GSH concentrations were 
calculated from the absorbanee  of the solutions at 412 
nm. A  blank value was obtained in parallel mixtures in 
which  all GSH was oxidized by addition of 5  /zl of 10 
mM diamide  to  the  supernate  before  addition  of the 
DTNB. 
The  rate  of  diamide  utilization  was  calculated  by 
measuring its rate of removal from the incubation me- 
dium.  Medium diamide was  titrated  by adding known 
amounts of GSH to aliquots of medium and determining 
the excess  GSH by the DTNB procedure  as described 
above. 2 mol of GSH are consumed by 1 tool of diamide. 
Oxidation 
Leukocyte suspensions  (5  x  10  e cells in 2 ml of PBS 
with  or  without  added  drugs)  were  incubated  with 
gentle shaking  for  10  min  at  37~  in closed Warburg 
flasks. The medium contained 0.1 mM glucose with [1- 
~4C]glucose at approximately 1 /.~Ci/ml. The center well 
held 0.2  ml of 0.25  M  NaOH and  a  paper wick. The 
reaction was terminated by tipping in 0.2 ml of 1 N HCl 
from  the  sidearm.  An  additional  2-h  incubation  with 
shaking  was allowed, to trap the radioactive CO2 liber- 
ated by the HCI. The radioactivity in the center well was 
then counted by liquid scintillation. 
RESULTS 
Con A  Cap Formation in Human PMN 
Induced by Diamide and BHP 
The typical distribution patterns of FITC-Con A 
on the surface of untreated,  diamide-treated,  and 
BHP-treated PMN are shown in the insets to Figs. 
1  and  2.  The  majority of untreated  cells show  a 
homogeneous labeling pattern  (Fig.  1, Inset). By 
contrast,  the majority of cells preincubated  for 5 
min with diamide (50 nmol/106 cells) followed by 
5-min labeling with FITC-Con A  show movement 
of the surface-bound  iectin into a  tight knob-like 
extension  at  one  pole of the  cell  (Fig.  2, Inset). 
BHP (50 nmol/106 cells) also promotes movement 
of Con A  into a surface cap at one pole of the cell. 
BHP-induced  caps  are  often  more  diffuse  than 
those  that  develop on diamide-treated  cells,  and 
capping is less frequently accompanied by forma- 
tion of a  tail or uropod. 
Dose-response data for capping, induced after a 
5-min preincubation of 106 leukocytes in 0.5 mi of 
PBS containing  various amounts  of diamide  and 
BHP,  are  given in Fig.  3  A  and  B.  Both  agents 
oxidize GSH by a  stoichiometric reaction. There- 
fore, although their doses are plotted for conveni- 
ence in molar concentrations, they are discussed in 
terms  of nanomoles  per  106  cells.  Diamide  pro- 
motes an extreme degree of capping when present 
in amounts between 25 and 250 nmol diamide/106 
cells. Lower doses are ineffective and amounts of 
diamide  above  500  nmol/106 cells are inhibitory. 
This inhibition at high concentrations  of diamide 
may reflect direct oxidation of surface or intracel- 
lular protein  sulfhydryl residues required  for the 
capping  process.  BHP  shows  a  broader  range  of 
effective  doses,  promoting  capping  between  25 
and  500  nmol/106  cells.  Doses  above  500  nmol 
BHP/108 cells appear to be toxic, since cells show 
increased fragility, decreased surface binding, en- 
hanced  diffusion  of FITC-Con A  into  cells,  and 
inhibition of cap formation. 
The data  in Table I  established  that  the extent 
of Con A  capping induced by a maximally effective 
dose of diamide (established above) is equal to the 
maximum  capping  response  that  can  be  induced 
by colchicine or R17934  (24). The maximum cap- 
ping response to BHP is consistently lower by 15- 
25%  than the maximal response to diamide. 
The data plotted in Fig. 4 show the time-course 
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mally effective doses of diamide and BHP. In the 
upper curves (A),  25  nmol/108 cells  diamide or 
BHP were  added at time zero, and the  medium 
was left unchanged during the  entire incubation 
period.  Both  agents  induced  a  high  degree  of 
capping during the first 20 rain of incubation, after 
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FIGURE 3  Concentration dependence of Con A  cap- 
ping induced by diamide and BHP. Cell suspensions (108 
leukocytes in 0.5 ml PBS) were preincubated for 5 min 
with amounts of diamide (A) or BHP (B) between 0.5 
nmol/106 (10  4  M) and 5 nmol/10  e cells (10  .2 M) before 
5-min labeling with FITC-Con A (10 gg/ml). Drug con- 
centrations are plotted on a logarithmic scale. Results 
are the average of two separate experiments. 
which  the  proportion  of  cells  that  capped  de- 
creased rapidly. Addition of a second portion of 
either drug after 60 min restored Con A  capping 
on the majority of cells. 
In the lower curves (B), 25 nmol/10  ~  cells diam- 
ide or BHP were present only during the first 10 
rain of incubation. Further incubation was carried 
out  in  fresh  medium  without  drugs.  As  antici- 
pated,  the  duration of the  increased capping re- 
sponse was shorter than in A  where  drugs were 
present for longer periods. Addition of fresh drug 
restored cap formation to high levels. 
It was established that diamide and BHP pro- 
mote  capping not  only in cells  pretreated  with 
drug before Con A  labeling, but also in cells that 
are prelabeled with Con A and subsequently incu- 
bated with GSH-oxidizing agents (Table II). This 
suggests that the drugs cause disassembly of pre- 
formed MT as well as preventing their assembly. 
The effect of exogenous GSH on Con A  cap- 
ping induced by diamide and BHP was also stud- 
ied. GSH alone does not alter the distribution of 
FITC-Con A on human PMN. Simultaneous addi- 
tion  of  excess  GSH  with  diamide  blocked  the 
action of diamide by exhausting it in direct chemi- 
cal reaction. However, pretreatment of cells with 
diamide (5 min) followed by GSH (5 rain) led to a 
full diamide-induced capping response. This indi- 
cates that once diamide has entered the cells, its 
action cannot be reversed by addition of the rela- 
tively impermeable tripeptide.  By  contrast with 
diamide, capping induced by BHP is not affected 
by the simultaneous presence of GSH, indicating 
that there is little or no direct interaction between 
BHP and GSH, at least during short incubation 
periods. 
During the course of these experiments, it was 
noted that lymphocytes, which form  15-20%  of 
the cell suspensions, are  also extensively capped 
by diamide and BHP. Monocytes are also capped. 
FIGURE 1  Fluorescence and electron micrographs of normal human PMN exposed to Con A (10 or 100 
ttg/ml, respectively) for 5 rain. Inset  shows the  typical uniform surface distribution of FITC-Con A. 
Ultrastructurally, PMN treated  with Con A  typically display many longitudinal microtubular profiles 
(arrows) emanating from the centriole (C). N = nuclear lobes, x  26,400. Scale bar = 2.0/~m. 
FIGURE 2  The inset illustrates the concentration of FITC-Con A on a capped PMN pretreated  with 
diamide (50 nmol/108 cells). An electron micrograph of a  PMN  similarly treated  with diamide and 
subsequently exposed to  Con  A; note  the  absence of centriole (c)-associated microtuhules and the 
pronounced accumulation of dense material beneath the capped cell protrusion. The cap is extensively 
plicated in contrast to the evenly-contoured noncapped membrane. N = nuclear lobes, x  10,600. Scale 
bar = 2.0 p.m. 
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Effects of  Agents Known to Inhibit MT assembly and Agents that Oxidize GSH on Con A 
Capping on Human PMN 
Distribution of fluorescence 
Line  Pretreatment  Time, min  Random  Patched  Capped 
1  PBS  10  86  8  6 
2  PBS  30  84  9  7 
3  Colchicine (10  -8 M)  30  8  4  88 
4  R17934 (5  ￿  10  -7 M)  30  9  4  87 
5  Diamide*  10  10  3  87 
6  BHP*  10  24  3  73 
Cells were pre-incubated with drugs at 37~  for the times indicated. FITC-Con A  (10/~g/ml) 
was present during the last 5-min period of incubation. Results are the average of five separate 
determinations. 
* 50 nmol/10  ~ cells. 
Effects of Diamide and BHP on 
GSH Levels 
It was not possible to measure GSH levels in the 
small numbers of leukocytes  (10  s  cells in 0.5  ml 
PBS) used in the capping assay. Therefore, larger 
numbers  of  cells  were  employed  (12-15  ￿  l0  s 
cells in 1 ml of PBS) and a proportional increase in 
the  amounts  of  added  diamide  and  BHP  was 
made,  to  maintain  the  ratio  of  nanomoles  anti- 
GSH reagent to cell number identical to the ratio 
employed for the capping experiments. 
The GSH levels in cell suspensions incubated at 
37~  with diamide and BHP at 25  nmol/10  ~ cells 
are shown in Fig. 5, A  and B. Diamide causes an 
abrupt  decrease  in  GSH  levels  from  a  control 
value of 1.7 nmol/10  n cells to about 30%  of con- 
trol in 5 min. This new steady-state level of GSH is 
maintained  for  approximately  20  min.  After  30 
min, no diamide remains in the medium and GSH 
levels are restored to normal. Since exhaustion of 
25  nmol of diamide implies oxidation of 50 nmoi 
of GSH,  the  GSH  pool  in these cells must have 
turned over 50/1.7  or about 30 times in 20 min. 
Similar data  (not shown)  were  obtained  with  50 
nmol diamide/106 cells, except that the GSH level 
remained at about 27% of control until 30 min. 
BHP also causes a  rapid decline followed by a 
rise  in  intracellular  GSH  levels.  However,  the 
decrease is smaller with BHP than with diamide- 
to  between  55  and  65%  of control  after  10  min 
with  25  nmol/10  ~ cells.  Using 50  nmol BHP/10  B 
cells,  GSH  levels  decreased  to  49%  of  control 
after  10  min  and  began  to  rise  towards  normal 
after 30 min. 
Although  lower  concentrations  of  BHP  and 
diamide (2 nmol/106 ceils) caused no measureable 
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FmuaE 4  Time-course of Con A  capping induced by 
diamide (0) and BHP (O). Cell suspensions  (10  e cells in 
0.5 ml PBS plus glucose [5  x  10  -a M]) were incubated 
at 37~  in the presence of 25 nmol of diamide or BHP. 
The solid bars above each curve show the total length of 
incubation without change of medium. Addition of fresh 
drug to cell suspensions is indicated by the dotted bars. 
FITC-Con A  (10 tzg/ml) was present during the last 5 
rain of incubation. 
decrease in GSH levels during a  5-min incubation 
at  37~  a  similar  incubation  at  4~  decreased 
GSH  to  between  0  and  10%  of  normal.  This 
926  THE  JOURNAL OF  CELL BIOLOGY" VOLUME 71,  1976 TABLE II 
Cap Formation Induced by Diamide and BlIP on PMN Prelabeled and Postlabeled with F1TC-Con A 
Distribution of Fluorescence, % 
Line  First incubation (I0 rain)  Second incubation (10 rain)  Random  Patched  Capped 
1  PBS  FITC-Con A  80  16  4 
2  FITC-Con A  PBS  60  30  10 
3  Diamide*  FITC-Con A  11  1  88 
4  FITC-Con A  Diamide*  7  12  81 
5  BHP*  FITC-Con A  21  12  67 
6  FITC-Con A  BHP*  22  20  58 
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Cells were collected by rapid centrifugation and resuspended in PBS between the first and second incubations.  Cells 
exposed to F1TC-Con A (10/zg/ml) during the first incubation period (lines 2, 4, 6) showed more patch formation 
than cells exposed to lectin only during the second incubation period (lines  1, 3, 5). This reflects internalization of 
Con A during extended incubation. Results are the average of two separate determinations. 
* 50 nmol/108 cells. 
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FIGURE 5  GSH  levels in  diamide-  and  BHP-treated 
leukocytes. Cell suspensions  (12.9  x  108 cells in 1.0 ml 
PBS-glucose  in  A;  15.8  x  106  cells  in  1.0  ml  PBS- 
glucose in B) were incubated at 37~  in the presence of 
25 nmol/10  e cells of diamide (A) or BHP (B). At various 
times,  the  cells  were  collected  by  centrifugation  and 
GSH levels determined in acid extracts. The solid lines 
show GSH levels in cells treated continuously with diam- 
ide or BHP. The dotted line shows the change in GSH 
levels after removal of drug and  10-min  incubation  in 
fresh PBS. The line joined by triangles in A  shows the 
amount of diamide present in the medium. All values are 
given as percent of values at time zero. In A, resting cells 
suggested that the mechanism for GSH regenera- 
tion is active only at the higher temperature. 
The most obvious pathway for the high rate of 
GSH  regeneration  in  ieukocytes  involves activa- 
tion of the  hexose  monophosphate  shunt  (HMS) 
and of the GSH reductase  catalyzed reduction of 
GSSG  by NADPH.  HMS  activity,  estimated  by 
the production of labeled CO2 from [1-14C]glucose 
was increased markedly and nearly equally (5  to 
10-fold)  by  diamide  or  BHP  during  a  10-min 
incubation at 37~ 
Con  A  (100  /xg/ml)  increased  [1-C14]glucose 
oxidation two- to threefold under the same condi- 
tions  (10-min  exposure  of  cells  to  Con  A  plus 
isotope) but had little effect on GSH levels: in five 
experiments  with  10-100  /~g/ml  Con  A,  GSH 
levels ranged  from  10%  below control  values to 
5%  above control. 
Electron  Microscopy 
Untreated  human  PMN  characteristically  dis- 
play  several  short  MT profiles associated  with  a 
juxtanuclear  centriole  complex  (10,  25)  (Table 
II1,  line  1).  Brief  exposure  to  Con  A  (5  min) 
contain  1.7  nmol  GSH/108 cells,  and  in  B,  1.4  nmol 
GSH/108 cells.  Assuming 0.347  /~l cell water/106  cells 
(9),  these values correspond to GSH concentrations of 
4.9 and 4.0 mM in cells from two separate donors. These 
results  are from single representative experiments. The 
variation between different donors in GSH levels was 
from  1.2  to  1.8  nmol/10  e cells  (3.6-5.1  mM).  Slight 
variability  in the percent reduction in GSH levels and in 
the duration of the depression was observed in cells from 
different donors.  However, the data were qualitatively 
similar and the rate of GSH regeneration was the same 
within  5 min between experiments. 
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(Fig. 1 and Table III, line 2). The number of MT 
visible  by  direct  counts  in  the  microscope  was 
increased four- to fivefold after Con A  binding, 
and the increase measured by micrograph counts 
was  approximately sevenfold. In addition to  an 
increased number of centriole-associated MT the 
length of these  MT was also greater  in Con A- 
treated  cells, and more  MT were  observed, but 
not quantified, in the peripheral cytoplasm (Fig. 
1).  Qualitatively similar observations have  been 
reported by Hoffstein et al. (10). 
Compared to cells treated with Con A  alone, 
addition of Con A to PMN previously exposed to 
diamide for 5 min or BHP for  10  rain produces 
striking changes in cellular organization (Fig. 2). 
First,  the  marked  increase  in  MT  observed  in 
control cells after Con A does not occur with drug 
treatment (Table III, lines 3 and 4). MT are also 
extremely rare in cells previously exposed to Con 
A  to induce assembly and then given diamide or 
BHP (not shown). Second, the cells show a dra- 
matic change in shape. Whereas control cells are 
rounded with uniformly ruffled surfaces, diamide- 
treated cells show a prominent capped region (Fig. 
2). The cap is observed as a knob-like extension of 
the cell surface which is highly plicated in contrast 
to the smooth contour of the remaining cell mem- 
brane. BHP followed by Con A produces a similar 
effect. The cytoplasm beneath the cap is extremely 
dense,  containing numerous 6-  and  10-nm fila- 
ments  (not  shown)  while  generally  excluding 
membrane-bounded organelles.  Caps  of  similar 
morphology accompanied by a marked diminution 
in MTs were  also observed in lymphocytes and 
monocytes in diamide or BHP- and Con A-treated 
samples. 
Inhibition  of MT assembly, like Con A capping, 
was  readily  reversible.  Thus,  PMN  exposed  to 
diamide for 10 min, and then in PBS alone for 30 
rain before Con A labeling, were indistinguishable 
from cells treated with Con A  alone in terms of 
cell  shape.  The  number of  centriole-associated 
MT under these conditions was slightly elevated 
over control (Table III, line 5). 
MT  Assembly  In  Vitro 
The effects of diamide and BHP on MT assem- 
bly in vitro were studied by the fluorescence en- 
ergy transfer method developed by Becker et al. 
(1). Basically, FITC- and RITC-tubulin are com- 
bined under polymerization conditions, the  mix- 
ture is excited near the absorption maximum for 
FITC (donor), and MT  assembly is  determined 
from the increase in emission from RITC (accep- 
tor).  Emission from RITC can occur only when 
RITC-  and  FITC-tubulins are  closely  approxi- 
mated, as when MT are assembled. We have pre- 
viously  shown  that,  under  polymerizing condi- 
tions, energy transfer (MT assembly) is evident at 
5 min and maximal at 15 min. Energy transfer fails 
to occur at 4 or 37~  in the presence of CaCl~ (4 
mM) or absence of GTP. 
Using this sensitive technique, we  found that 
pretreatment of labeled tubulins with 1 mM diam- 
ide for 1 h at 4~  or addition of I mM diamide just 
before incubation at 37~  totally inhibits MT po- 
lymerization. The effect of diamide is not reversed 
by addition of 4 or 10 mM GSH to the polymeriz- 
ing mixture 5 min after addition of diamide, but 
GSH (2 raM) added simultaneously does protect 
against inhibition, suggesting that GSH is a  pre- 
ferred substrate for oxidation by diamide. Diam- 
ide is also capable of depolymerizing MT. Rapid 
disappearance (within 7  min) of energy transfer 
follows addition of diamide (1.0 mM) to suspen- 
TABLE III 
Microtubule  Counts in  Untreated and Con A-Treated Human Neutrophils 
Counting  procedure 
Line  Treatment  A  B 
MT +- SEM 
1  PBS  1.1 +- 0.4 (52)  2.6 +- 0.4 (11) 
2  Con A  4.9 -+ 0.3 (48)  17.7 -+ 2.5 (17) 
3  Diamide-Con A  0.6 -+ 0.2 (17)  2.8 -  0.6 (8) 
4  BHP-Con A  2.3 _+ 0.5 (18)  3.6 -  1.1 (9) 
5  Diamide-PBS-Con  A  6.3 -+ 0.6 (15)  25.0 -+ 1.4 (7) 
MT were counted by (A) direct examination of centriolar regions in the electron microscope or 
(B) from micrographs of the centriolar area as described in the text. MT, mean number of MT 
profiles. Number of cells examined is given  in parentheses. 
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with the effects of diamide on MT assembly deter- 
mined  by  Mellon  and  Rebhun  (20)  using  light 
scattering  to  follow  MT  polymerization, except 
that  the  latter  workers  observed  a  reversal  of 
diamide inhibition after addition of 10 mM GSH 
to the polymerization mixture. 
BHP  (0.1-1.0  mM),  which  effectively causes 
dissolution of MT in vivo, is without effect on the 
in  vitro  assembly of MT  as  determined  by  the 
energy transfer technique. 
Negative  staining  of samples used  for  energy 
transfer studies showed abundant MT in control 
and BHP-treated mixtures. No recognizable MT 
were present in diamide-treated mixtures. 
DISCUSSION 
The importance of free SH groups for the polym- 
erization  of MT  in  vitro  was  first  indicated by 
Kuriyama  and  Sakai  (17).  Reaction  of  N- 
ethylmaleimide,  p-chloromercuribenzenesulfonate 
(PCMBS) or DTNB with 2 mol of SH per mole of 
tubulin dimer blocked tubulin polymerization and 
depolymerized preformed  MT.  GSH,  which  ac- 
counts for over 90% of the nonprotein SH groups 
of the  cell and  participates in  a  variety of SH- 
exchange reactions, is a  likely candidate for pro- 
tecting these essential residues against oxidation in 
vivo. 
The  first  evidence  for  a  role  of GSH  in  MT 
assembly in vivo was obtained by studies in fertil- 
ized sea urchin embryos. Rebhun and co-workers 
(21,  28)  showed  that  treatment  of dividing sea 
urchin  embryos with  diamide prevented  mitotic 
spindle formation and caused rapid dissolution of 
existing spindles.  This  response  to  diamide was 
presumed to be a direct result of GSH oxidation. 
The  present  data  indicate  that  maintenance  of 
GSH levels is required for the assembly and pres- 
ervation of not only spindle but also cytoplasmic 
MT.  Several mechanisms which may resolve the 
relationship of GSH to MT are discussed below. 
We first established that treatment of cells with 
diamide or BHP promotes Con A  cap formation 
on human PMN. Con A  capping on PMN has so 
far been observed only in cells treated with anti- 
MT agents and in ceils from mice and patients with 
Chediak-Higashi syndrome in which Con A  bind- 
ing fails to stimulate MT assembly (22-27). These 
data immediately suggested that agents that oxi- 
dize GSH inhibit cytoplasmic MT assembly. Both 
reagents  promoted  capping  on  cells  prelabeled 
with Con A  and subsequently exposed to diamide 
or BHP. This suggested not only inhibition of MT 
assembly but also depolymerization of assembled 
MT. 
Electron microscope examination of control and 
treated PMN established a direct relationship be- 
tween  Con  A  capping  induced by  diamide  and 
BHP and inhibition of MT assembly. Untreated 
normal  PMN  have  few  assembled  MT.  Con  A 
binding is followed after 5 min by the appearance 
of  many  MT  emanating  from  centrioles  and 
coursing  towards  the  cell  periphery.  Cells  pre- 
treated with diamide followed by Con A  showed 
prominent uropods (caps) and an almost complete 
absence  of  MT.  Similarly, very  few  MT  were 
present after Con A  labeling in BHP-treated cells. 
It is apparent that the anti-MT effects of diam- 
ide and  BHP  are observed only when  sufficient 
drug is present to reduce  GSH levels and that a 
highly active mechanism for maintenance of GSH 
levels operates in human PMN. The rapid regen- 
eration of GSH after oxidation to GSSG is most 
likely a consequence of the highly active HMS in 
these  ceils.  As  noted,  both  diamide  and  BHP 
stimulated the HMS between 5- and  10-fold dur- 
ing  a  10-min  incubation.  The  HMS  provides 
NADPH required for the reduction of GSSG by 
GSH reductase. 
By  using  BHP  as  well  as  diamide  to  oxidize 
GSH,  we  were  able to  minimize the  possibility, 
recognized  by  Rebhun  and  co-workers  (20)  in 
their studies of the role of GSH in assembly of the 
mitotic apparatus, that MT disruption is a result of 
direct  oxidation of tubulin-SH  by  the  reagents. 
Although diamide can directly inhibit MT assem- 
bly and  cause  depolymerization of MT  in vitro, 
BHP has no direct effect on MT assembly in vitro 
or presumably in vivo. Thus,  the  effects we  ob- 
serve are most likely secondary to GSH oxidation 
and not a result of direct tubulin oxidation by the 
drugs. Several other lines of evidence also argue 
against a  direct action  of diamide in  vivo upon 
cytoplasmic MT  in  PMN.  It  was  observed that 
GSH completely protects against inhibition of MT 
assembly by  diamide  in  vitro.  Diamide-induced 
capping and MT disassembly in PMN in vivo occur 
when substantial amounts of GSH (at least 30% 
of normal) are present so that a  protective effect 
of GSH against direct diamide-tubulin interaction 
should persist. In addition, the inhibition of MT 
assembly in vitro by diamide is not reversible in 
our hands by GSH  or other treatment.  By con- 
trast,  MT  integrity is  restored  as  soon  as  GSH 
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in vivo. 
The sum of these data leads to the conclusion 
that GSH is essential for MT assembly and preser- 
vation in vivo. However, it is clear that  various 
stimuli which induce MT polymerization do  not 
affect the levels of intracellular GSH. This is true 
both for the  Con A-treated PMN in our experi- 
ments and for mitosis in the fertilized sea urchin 
egg  (11,  12, 20, 28). Therefore, we do not pro- 
pose that changes in GSH levels necessarily initi- 
ate MT assembly but rather that maintenance of 
GSH levels is required to  permit or to  preserve 
polymerization of MT. 
This point becomes significant when  we  con- 
sider that  the  MT assembly which  accompanies 
Con A  binding and phagocytosis in human PMN 
and fertilization in the sea urchin egg occurs simul- 
taneously with the production of oxidants. In the 
case of PMN, it is established that both stimuli of 
MT assembly also promote the production of sub- 
stantial amounts of superoxide and H~O2 (3, 29). 
H202 would be expected to promote GSH oxida- 
tion  either  by  direct  chemical  reaction  or  as  a 
substrate  for  GSH  peroxidase.  Indeed,  we  find 
that  PMN  treated  for  5  rain  with  Con  A  plus 
exogenous H202 (250 nmol/10  e cells) show a 50% 
reduction in GSH levels and that approximately 
65%  of  cells  are  capped  (J.  M.  Oliver,  D.  F. 
Albertini, and R. D. Berlin, unpublished results). 
The intriguing possibility exists that tubulin itself 
may act as an oxidant by consuming reduced SH 
equivalents (as GSH) during MT polymerization. 
No direct in vivo data are available on this point, 
but several older reports claim that oxidative re- 
sponses are depressed when PMN phagocytize in 
the  presence of colchicine (4,  7,  18,  19). Thus, 
MT assembly is dependent on the ability of cells to 
maintain GSH levels in the face  of the oxidative 
challenge  from  endogenous  H20~  and  perhaps 
from tubulin. Suitable mechanisms are available in 
human PMN. It is established that the activity of 
GSH reductase is increased within 15 s of initia- 
tion  of  phagocytosis  (31)  and  that  the  HMS 
(turned  on  most  effectively  by  decreased 
NADPH/NADP  § ratios in the presence of GSSG 
[5])  is  stimulated after  phagocytosis  or  Con  A 
binding (3,  14).  Fertilization in sea  urchin eggs 
has qualitatively the  same metabolic accompani- 
ments-increased 02 consumption (6),  and con- 
comitant HMS activation (13) and GSH reductase 
activation (11,  12). These latter responses repre- 
sent elements of a mechanism for GSH homeosta- 
sis.  Thus,  MT  assembly can  be  initiated in  re- 
sponse to surface-binding  events (in PMN) or after 
fertilization (in sea urchin eggs)  despite the well- 
documented increase in oxidative metabolism. We 
suppose  that the  oxidative challenge induced by 
diamide, BHP, and high concentrations of exoge- 
nous H202 is greater than that induced by surface 
binding or fertilization so that GSH levels cannot 
be maintained and MT assembly is inhibited. 
The overwhelming oxidation of GSH by diam- 
ide or BHP could lead to oxidation of tubulin and 
thus  inhibition of  MT  assembly by  one  of two 
mechanisms. The  first is that  GSSG itself is the 
immediate tubulin oxidant. If this  were  so,  one 
would predict that GSSG per se would inhibit MT 
assembly in vitro. We have confirmed the report 
of Mellon and Rebhun (20) that indeed 10 mM 
GSSG prevents polymerization of isolated tubu- 
lin. However, we find that 4 mM GSSG (equiva- 
lent at least to four times the GSSG concentration 
of PMN where diamide or BHP are used to reduce 
GSH levels by 50%) neither alters the assembly of 
MT nor effects the disassembly of MT in vitro (D. 
F. Albertini and R. D. Berlin, unpublished obser- 
vations). Thus,  the  in  vivo effect  of  decreasing 
GSH  (increasing GSSG) does  not appear to  be 
mimicked in vitro by a direct action of GSSG at 
well  above the physiologically attainable concen- 
tration range for PMN. Of course, an enzymatic 
couple between GSH, GSSG, and tubulin SH may 
exist  in  vivo  but  be  missing from  the  purified 
tubulin used in our in vitro studies. 
The second mechanism puts the process into the 
perspective of GSH homeostasis and the physio- 
logic oxidative challenge. According to this mech- 
anism,  GSH  normally serves  as  a  trap  for  the 
H202 generated after Con A binding. When GSH 
levels are depressed, some H202  remains free to 
oxidize tubulin SH. The presence of GSSG serves 
only to indicate that the defense mechanism has 
been overwhelmed. In support of this, we find that 
H~O2 oxidizes tubulin SH residues and is a potent 
inhibitor of  MT  polymerization in vitro  (D.  F. 
Albertini and R. D. Berlin, unpublished results). 
Either mechanism would suggest potential path- 
ways  for the  physiological regulation of MT as- 
sembly. 
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